SCHEMBL3073772

SCHEMBL3073772

C=CCC(CC=C)(OC(N)=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.58
ALDH1A1 P00352 4/20 0.53
TSHR P16473 2/20 0.53
KMT2A Q03164 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 3/20 0.38
CYP2C19 P33261 2/20 0.37
HIF1A Q16665 1/20 0.37
KDM4E B2RXH2 3/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP3A4 P08684 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
KCNN4 O15554 2/20 0.34
PKM P14618 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11005490 0.81 HTT (0.55) HTTALDH1A1TSHRKMT2ASMN1; SMN2
SCHEMBL6139504 0.76 TSHR (0.50) HTTALDH1A1TSHRKMT2ASMN1; SMN2
SCHEMBL3083611 0.75 KMT2A (0.43) HTTTSHRKMT2AMEN1MAPT
SCHEMBL5962490 0.74 HTT (0.46) HTTALDH1A1TSHRKMT2ASMN1; SMN2
SCHEMBL7167864 0.74 HTT (0.69) HTTALDH1A1TSHRKMT2ASMN1; SMN2
SCHEMBL251792 0.73 ALDH1A1 (0.47) HTTALDH1A1TSHRKMT2ASMN1; SMN2
SCHEMBL27830529 0.72 HTT (0.45) HTTALDH1A1TSHRKMT2ASMN1; SMN2
SCHEMBL27696956 0.72 KIF11 (0.40) HTTALDH1A1TSHRKMT2AMEN1
SCHEMBL1908316 0.72 ALDH1A1 (0.65) HTTALDH1A1TSHRKMT2ASMN1; SMN2
SCHEMBL3613086 0.72 ALDH1A1 (0.65) HTTALDH1A1TSHRKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101535305-B 5-hydroxymethyl-oxazolidin-2-one derivatives ACTELION PHARMACEUTICALS LTD 2013-09-18 CN disclosed
US-7795166-B2 Functional group-selective hydrogenation catalyst and functional group-selective hydrogenation method N.E. CHEMCAT CORPORATION (JP) 2010-09-14 US disclosed
CN-101535305-A 5-hydroxymethyl-oxazolidin-2-one derivatives ACTELION PHARMACEUTICALS LTD (CH) 2009-09-16 CN disclosed
US-20070155617-A1 FUNCTIONAL GROUP-SELECTIVE HYDROGENATION CATALYST AND FUNCTIONAL GROUP-SELECTIVE HYDROGENATION METHOD N. E. CHEMCAT CORPORATION (JP) 2007-07-05 US disclosed